Skip to main content
Caplight Logo









ChomiX Biotech

ChomiX Biotech

Private
NanjingHealthcare & Life Scienceshttps://www.chomixbio.com/

Last Round

Early Funding

May 15, 2023

Company Overview

ChomiX Biotech is a biotechnology company that provides drug discovery services and develops innovative small molecule therapeutics using its proprietary chemoproteomics platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

chemoproteomicsdrug discoverylive-cell screeningtarget identificationsmall molecule therapeuticsundruggable targetsactivity-based protein profilingABPPchemical biologylead optimizationbio-orthogonal chemistryprotein labelingpreclinical researchcontract research organizationCROtarget discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ChomiX Biotech Comparables

Compare ChomiX Biotech with similar companies based on industry and business-model similarity.

ChomiX Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Belharra Therapeutics
82%
BridGene Biosciences
80%
Momentum Biotechnologies
80%

ChomiX Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 15, 2023
Corporate FundingJan 1, 2022
AngelJun 1, 2021

Key People

Founding team and executive leadership

Nan Chen

Chief Executive Officer

Executive Team

ChomiX Biotech Investors

Notable investors and investment history

ChomiX Biotech investors
InvestorRounds
Tigeryeah CapitalEarly Funding
Tsinghua Innovation VenturesEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors grew 1250% MoM, reaching 2.1K.

  • Apr 3, 2026

    Monthly visitors increased 498% MoM.

ChomiX Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ChomiX Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ChomiX Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range6
Year Founded2021
Last FundingMay 15, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?